$MYL News U.S. stocks: Dow closes above 17,000 4:03

New Post Public Reply Private Reply Replies (0) Message Board

Jul 15, 2014 at 1:52 PM

$MYL News

U.S. stocks: Dow closes above 17,000 4:03 p.m. July 14, 2014 - Anora Mahmudova
Tesla, Citigroup gain; GoPro tumbles 3:41 p.m. July 14, 2014 - Angela Johnson
Stocks end with solid gains, but Dow can't hang on for record close: live blog recap 3:31 p.m. July 14, 2014 - blogs.marketwatch.com
Mylan shares rise 4.6% in premarket 7:59 a.m. July 14, 2014 - Tomi Kilgore
Abbott Labs to sell part of generics business for $5.3 billion 7:35 a.m. July 14, 2014 - Anna Prior
Tesla sued in China; Groupon gets upgrade 2:21 p.m. July 8, 2014 - Sue Chang
Apple falls on Beats news; Tesla recovers from selloff 3:57 p.m. May 9, 2014 - Sue Chang
Plug Power tanks on fuel-cell criticism; Pfizer gains 3:47 p.m. April 28, 2014 - Sue Chang
European shares up; AstraZeneca surges on M&A prospect 12:16 p.m. April 28, 2014 - Carla Mozee
Health-care market rises on Merger Monday deals 11:52 a.m. April 28, 2014 - Russ Britt
Mylan shares slump 8.9% after Meda rejects new bid 8:01 a.m. April 28, 2014 - Silvia Ascarelli
Meda rejects sweetened merger bid from Mylan 2:35 a.m. April 28, 2014 - MarketWatch.com
20 stocks that should see boost as investors seek stability: S&P's Stovall 1:19 p.m. April 21, 2014 - blogs.marketwatch.com
Mylan shares extend losses to slide 1.8% 9:33 a.m. April 8, 2014 - Sue Chang
U.S. stocks sell off; Nasdaq drop worst in 2 months 4:43 p.m. April 4, 2014 - Anora Mahmudova
Mylan shares gain 5.5% to lead S&P 500 9:32 a.m. April 4, 2014 - Sue Chang
Mylan eyes takeover of Swedish drug maker Meda 9:14 a.m. April 4, 2014 - Jonathan D. Rockoff
Mylan may buy Swedish pharma group Meda: WSJ 2:57 a.m. April 4, 2014 - Barbara Kollmeyer
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:24 p.m. March 24, 2014 - Sue Chang

Why Mylan (MYL) Stock Is Climbing Today 12:24 p.m. Today - TheStreet.com
Stock Market News for July 15, 2014 - Market News 10:10 a.m. Today - Zacks.com
Trade-Ideas: Mylan (MYL) Is Today's Unusual Social Activity Stock 10:09 a.m. Today - TheStreet.com
Mylan - Much Anticipated Specialty And Branded Generics Deal With Abbott Is Finally A Reality 9:52 a.m. Today - Seeking Alpha
UPDATE: Bank Of America Reiterates On Mylan Following Abbott Transaction 7:49 a.m. Today - benzinga.com
Hottest Healthcare Stocks Now – MYL DGX LH AZN 7:30 a.m. Today - InvestorPlace.com
'Fast Money' Recap: Will Apple's Next Phone Be Delayed? 5:00 a.m. Today - TheStreet.com
Race to Cut Taxes Fuels Urge to Merge 7:37 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
U.S. Stands to Lose Billions From Corporate-Tax Inversions 5:32 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
Mylan, AbbVie News Shows Tax Inversion Boom Continues 4:30 p.m. July 14, 2014 - Investors Business Daily
Stock Market Today: Dow Surges Above 17,000 as Citigroup Tops Street 4:14 p.m. July 14, 2014 - TheStreet.com
European Companies Fear U.S. 'Inversion' Takeovers 2:33 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
AbbVie, Shire Near $54 Billion Deal 2:13 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
Why Pharma Is Flocking to Inversions 1:53 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Dow Above 17,000 as Citigroup Reaches $7B MBS Settlement 12:24 p.m. July 14, 2014 - TheStreet.com
Mylan Gets Abbott Generics Business in $5.3B Deal 11:02 a.m. July 14, 2014 - TheStreet.com
Mylan Buying Abbott Generics Unit, Moving Abroad 10:27 a.m. July 14, 2014 - Investors Business Daily
Abbott, Mylan Join Forces to Dodge U.S. Taxes 10:03 a.m. July 14, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – MYGN MYL QCOR CNC 9:30 a.m. July 14, 2014 - InvestorPlace.com
Generic Drug Stocks Soar – Your Best Healthcare Plays are TEVA and MYL 4:53 a.m. July 14, 2014 - InvestorPlace.com

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 6:30 a.m. July 14, 2014 - PR Newswire - PRF
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Mylan Launches Generic Micardis® Tablets 7:30 a.m. July 8, 2014 - PR Newswire - PRF
Mylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014 1:02 p.m. July 1, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW 5:10 a.m. June 30, 2014 - PR Newswire - PRF
Mylan Launches Generic Actonel® Tablets, 150 mg 11:49 a.m. June 11, 2014 - PR Newswire - PRF
Critical Alerts For eBay, JA Solar, Mylan Laboratories, Future Fuel, and 51Job Technology Released By InvestorsObserver 9:31 a.m. June 11, 2014 - PR Newswire - PRF
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 5:50 a.m. June 11, 2014 - PR Newswire - PRF
Mylan Launches Generic Paraplatin® Injection 7:30 a.m. June 9, 2014 - PR Newswire - PRF
Mylan to Present at the Goldman Sachs 35th Annual Global HealthCare Conference 8:45 a.m. June 5, 2014 - PR Newswire - PRF
Pharma Stocks under Review -- Research on Mylan, Sanofi, Impax Laboratories, and Dr. Reddy's Laboratories 7:30 a.m. June 3, 2014 - PR Newswire - PRF
Upcoming Shareholders Meeting, Multi-Choice Medical Plans, FDA Approvals, and Investor Conference Schedules - Analyst Notes on Biogen Idec, UnitedHealth Group, Amgen, WellPoint and Mylan 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Pro Football Player Adrian Peterson is Calling on Americans to be Ready2Go™ and Learn How to be Aware and Prepared for Anaphylaxis 7:30 a.m. June 2, 2014 - PR Newswire - PRF
Mylan Settles Patent Litigation Related to Celebrex® Capsules 7:00 a.m. June 2, 2014 - PR Newswire - PRF
Mylan Believes Court Erred in its Ruling Regarding Generic Celebrex® 12:43 p.m. May 30, 2014 - PR Newswire - PRF
Mylan Launches Generic Malarone® Tablets 7:30 a.m. May 29, 2014 - PR Newswire - PRF
Mylan to Present at the INVEST Pennsylvania Equity Conference 10:19 a.m. May 28, 2014 - PR Newswire - PRF
Secondary Offering, Appointments, and Clinical Developments - Analyst Notes on HCA, Biogen Idec, WellPoint, AbbVie and Mylan 7:00 a.m. May 23, 2014 - PR Newswire - PRF
Company Updates, Takeover Offers, Stock Price Movements, and FDA Approvals - Analyst Notes on Chubb, Valeant, AstraZeneca, Mylan and Perrigo 7:00 a.m. May 20, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...